Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: A case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34195147.
- Also identified by DOI 10.4103/jfmpc.jfmpc_2271_20 and PMC identifier 8208211.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three independent cases of adult patients are described who had relative control of their type 2 diabetes prior to infection with COVID-19. Each of the described patients had different levels of severity of COVID-19 but all experienced significant and prolonged hyperglycemia for at least 1-2 months after resolution of their COVID-19 infection. Two of the three patients required intensifying insulin regimens for two months after COVID-19 infection. The case study helps to inform primary care providers about the possible need for the intensification of antihyperglycemic medications for several weeks to months after the resolution of COVID-19 infection to minimize prolonged hyperglycemia.